Cel-sci's phase 3 population analysis for upcoming confirmatory registration study in head & neck cancer demonstrates well balanced patient population, confidence in clinical results

Vienna, va.--(business wire)---- $cvm #multikine--cel-sci's phase 3 population analysis for upcoming confirmatory registration study in head & neck cancer demonstrates well balanced patient population.
SCI Ratings Summary
SCI Quant Ranking